ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2872

B-Cell Autoepitope and Tetramer Analysis Reveals Expansion of Apoptotic Autoantigen La and snRNP Reactive B Cells in BXD2 Mice

Jennie Hamilton1, Jun Li2, Qi Wu3, PingAr Yang3, Bao Luo3, Hao Li4, Troy Randall5, John Edwin Bradley5, Justin J. Taylor6, John D. Mountz7,8 and Hui-Chen Hsu3,4, 1University of Alabama at Birmingham, Birmingham, AL, 2Med - Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 4Department of Medicine, Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 5Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 6Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 7Dept of Med/Rheumatology Div, University of Alabama at Birmingham, Birmingham, AL, 8Birmingham VA Medical Center, Birmingham, AL

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Apoptosis, autoantibodies, autoantigens and interferons, B cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose

Systemic lupus erythematous (SLE) is characterized by production of highly pathogenic IgG autoantibodies (autoAbs).  While serum autoAb profiling is standard, it remains challenging to isolate authentic autoreactive B cells that give rise to these autoAbs.  Similar autoAbs are spontaneously produced in lupus-prone BXD2 mice that display apoptotic cell clearance defects and heightened type I interferon (IFN) signals.  The purpose of this study is to develop a comprehensive autoepitope and tetramer strategy to identify the dominant autoantigens (autoAg) and the underlying mechanisms promoting the development of autoreactive B cells in BXD2 mice.

Methods

A PEPperPRINT Autoimmunity Microarray covering 3,653 database derived, linear B-cell autoepitopes was probed with B6 and BXD2 serum to determine IgM and IgG binding reactivity.  Top peptides were selected for 3D crystal structural analysis.  A panel of over 50 peptide epitopes were verified by ELISA and ELISPOT.  Two epitopes from RNA-binding lupus La and 70 kDa U1snRNP were used to generate B cell tetramers for characterization of Ag-specific subpopulations of B cells.  

Results

The dominant epitopes recognized by BXD2 autoAbs are those commonly found in human SLE patients. Many immunodominant epitopes are located in cryptic regions of the native protein.  The strongest autoAb response was observed with nuclear peptides from RNA binding proteins (RBP) including lupus La13-27  LEAKICHQIEYYFGD, U1snRNP357-373SHRSERERRRDRDRDRD, and SmD197-111RGRGRGRGRGRGRG.  Other nuclear autoAgs include histones, centromere, and RNA polymerase III.  Tetramer analysis revealed a significant expansion in La+ and snRNP+ memory B cells and marginal zone precursor (MZ-P) B cells in BXD2 vs. B6 in both the circulation and the spleen.  Phenotype analysis of tetramer+MZ-P B cells showed upregulation of type I IFN inducible activation molecules CD69 and CD86 in BXD2 mouse spleens.

Conclusion

The bona fide presence of RBP cryptic autoAgs that were not predicted by Ag prediction programs is consistent with the previous finding that defective clearance of apoptotic blebs in BXD2 mice leads to production of autoepitopes that break B cell tolerance.  The potential activation of the TLR7 pathway by RBPs in combination with the upregulation of type I IFN response in Ag-specific MZ-P B cells further suggest that expanded tetramer+ MZ-P B cells may be a result of apoptotic cell clearance defects.  In light of our previous findings that MZ-P B cells are exceptional apoptotic Ag delivery MHCIIhi, CD86hicells and can stimulate CD4 T cells, these results suggest that specific targeting on TLR7 and type I IFNs may be important to eliminate autoAg-specific B cells.

Grant support: NIH 1RO1 AI 071110, NIH 1RO1 AI083705, NIH P30 AR048311, Veterans Affairs Merit Review Grant 1I01BX000600, Rheumatology Research Foundation, Lupus Research Institute, and Arthritis Foundation Post-doctoral Fellowship


Disclosure:

J. Hamilton,
None;

J. Li,
None;

Q. Wu,
None;

P. Yang,
None;

B. Luo,
None;

H. Li,
None;

T. Randall,
None;

J. E. Bradley,
None;

J. J. Taylor,
None;

J. D. Mountz,
None;

H. C. Hsu,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/b-cell-autoepitope-and-tetramer-analysis-reveals-expansion-of-apoptotic-autoantigen-la-and-snrnp-reactive-b-cells-in-bxd2-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology